COVID-19 VACCINE: BHARAT BIOTECH'S COVAXIN SAFE, PHASE II TRIALS TO START IN SEPTEMBER

Highlights

• Total 375 volunteers across 12 sites in India have been given two shots of this COVID-19 vaccine

• As per the reports, no adverse effects were observed at any of the site and the phase 2 trails will start in the month of September

• COVAXIN was developed from a SARS-CoV-2 strain of the coronavirus isolated by the NIV, Pune

After Russia announced registration of world’s f....